2004 International Conferce on Test
DOI: 10.1109/test.2004.1387352
|View full text |Cite
|
Sign up to set email alerts
|

Concurrent testing of droplet-based microfluidic systems for multiplexed biomedical assays

Abstract: We present a concurrent testing methodology for detecting catastrophic faults in droplet-based microfluidic systems and investigate the related problems of test planning and resource optimization. We apply this methodology to a droplet-based microfluidic array that was fabricated and used to perform multiplexed glucose and lactate assays. The test approach interleaves test application with the biomedical assays and prevents resource conflicts. We show that an integer linear programming model can be used to min… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
70
0

Publication Types

Select...
4
2
1

Relationship

1
6

Authors

Journals

citations
Cited by 41 publications
(70 citation statements)
references
References 22 publications
0
70
0
Order By: Relevance
“…In addition, we investigate the problem of fault diagnosis. We apply this methodology to a real-life biochip performing multiplexed biochemical assays, and compare our results with the results reported in [20].…”
Section: Introductionmentioning
confidence: 91%
See 3 more Smart Citations
“…In addition, we investigate the problem of fault diagnosis. We apply this methodology to a real-life biochip performing multiplexed biochemical assays, and compare our results with the results reported in [20].…”
Section: Introductionmentioning
confidence: 91%
“…It is based on a graph model of the microfluidic array and a problem formulation based on Hamiltonian paths in a graph. An efficient concurrent testing method that interleaves test application with a set of bioassays was proposed in [20]. Reconfiguration and defect tolerance techniques for biochips were described in [17,21].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…This cost-effective test methodology facilitates on-line testing, which allows fault testing and biochemical assays to run simultaneously on a microfluidicsbased biochip [14].…”
Section: Introductionmentioning
confidence: 99%